In recent years, the healthcare system in the United States has seen notable changes, especially with the growth of hospital-owned physician practices. This shift has significant effects on Group Purchasing Organizations (GPOs), as the traditional purchasing dynamics in healthcare are changing. Medtronic’s recent decision to end multiple contracts with Novation, the largest healthcare GPO, has captured attention, sparking conversations about the future role of GPOs in a consolidating healthcare system.
GPOs have long been important in the healthcare supply chain. Their main purpose is to combine purchasing volumes from member hospitals and other healthcare facilities, which gives them the ability to negotiate lower prices with manufacturers and wholesalers. GPOs also provide administrative support, contract management, and other services that can result in cost savings for their members. By harnessing collective buying power, GPOs can secure discounts that individual hospitals may struggle to achieve.
However, this conventional model faces challenges as more physician practices are owned by hospitals. Research indicates that over half of these practices are now hospital-owned, presenting new difficulties for GPOs. As healthcare systems merge, they gain increased negotiating strength, allowing them to bypass GPOs and negotiate directly with manufacturers for better pricing. This evolution raises questions about how GPOs can maintain their relevance and value in this changing environment.
A significant trend impacting GPOs is the consolidation of hospital systems. Larger healthcare organizations can negotiate more favorable terms because of their size and influence in the market. For example, Medtronic’s cancellation of five contracts with Novation, worth $2 billion, highlights this development. With Medtronic accounting for about 5% of Novation’s total volume, the cancellation raises concerns about the sustainability of GPO business models.
Jim Fields, an observer of the GPO sector, believes that GPOs may have reached their limit of effectiveness. Many traditional GPO functions can now be automated or provided by other service providers due to technological advancements. Fields suggests that the absence of competitive discounts from GPOs, as compared to direct manufacturer contracts, makes them less appealing.
Moreover, the increased role of wholesalers and pharmacy benefit managers (PBMs) in healthcare purchasing complicates the situation for GPOs. These entities can offer contracts and pricing options that compete directly with those of GPOs. As hospital systems continue to consolidate, GPOs will need to adjust their service offerings and consider new contracting methods to stay relevant.
As hospital practice ownership grows, GPOs confront several challenges:
In light of these challenges, GPOs must adjust and develop their business models. Several strategies may help GPOs maintain relevance:
GPOs should transition from just negotiating prices to offering additional services that assist member organizations in enhancing their operations and reducing costs beyond purchasing. This could involve consulting for practice operations, solutions for supply chain management, and data analysis to identify cost-saving opportunities.
Integrating advanced technology and AI into GPO services can improve efficiency and member engagement. By automating routine tasks, GPOs can allocate resources to more valuable activities. For example, AI in workflow management can help GPOs improve service delivery, manage contracts better, and support practices in making informed purchasing decisions based on real-time data analysis.
GPOs should rethink their contracting strategies in response to increased hospital consolidation. Instead of focusing solely on volume pooling, innovative approaches like tiered pricing, specialized contracts for high-demand products, and joint purchasing agreements with major hospital systems could make GPOs more attractive.
The use of AI and workflow automation offers an opportunity for GPOs and their members. As healthcare administrators look for efficient methods of managing purchasing, AI can significantly improve operational efficiency and provide actionable data.
AI can automate repetitive tasks related to purchasing, contract management, and inventory control. By employing machine learning algorithms, GPOs can analyze purchasing patterns, uncover cost-saving opportunities, and predict needs based on past data, thus streamlining the entire purchasing process for healthcare providers.
With predictive analytics, healthcare administrators can gain deeper understanding of purchasing decisions. AI can evaluate market trends and past data, enabling GPOs to offer tailored recommendations to their members. This leads to more informed decision-making, benefiting both hospitals and physician practices.
GPOs can utilize AI-driven platforms to enhance member engagement. By creating user-friendly interfaces and using chatbots for customer inquiries, GPOs can boost member satisfaction and communication. Improved interactions can build loyalty and encourage participation in GPO programs.
There is a notable trend towards specialized implantable devices that fall under the category of “physician preference.” AI can help GPOs negotiate contracts that address these specific needs, providing value for member organizations requiring specialized products.
The rise of hospital-owned physician practices has a significant impact on the relevance and operational strategies of GPOs. As hospital systems consolidate further, their increased bargaining power over manufacturers raises questions about the future of GPOs in healthcare purchasing. However, by focusing on value-added services, adopting technology, and reconsidering their contracting strategies, GPOs can shape a future that remains beneficial for their members.
Facing the ongoing challenges and opportunities from hospital consolidation and changing purchasing processes, GPOs must act promptly. Embracing AI and workflow automation will be vital for GPOs to provide competitive, value-driven services in the evolving healthcare purchasing environment.
For medical practice administrators, owners, and IT managers, the implications of this shift highlight the need for vigilance and adaptability. Understanding the changing landscape and leveraging technology will be essential for navigating the complexities of healthcare purchasing, particularly as GPOs redefine their roles in this new context.
Medtronic canceled five contracts for cardiovascular and orthopedic products with Novation, amounting to a total annual value of $2 billion, raising concerns about the future of GPOs.
GPOs pool purchase volumes from member hospitals to negotiate lower prices with manufacturers and wholesalers, providing administrative support and contract management.
GPOs face several threats, including hospital system consolidations allowing direct manufacturer negotiations, competition with wholesalers, adapting to new service demands from hospital-owned physician practices, and challenges from pharmacy benefit managers (PBMs).
Medtronic’s direct contracting approach questions the GPO business model, potentially prompting other manufacturers to reconsider their relationships with GPOs, thereby threatening the latter’s viability.
The top GPOs include Novation ($37.8B), Premier ($36.0B), MedAssets/Broadlane ($35.0B), HealthTrust Purchasing Group ($17.0B), and Amerinet ($7.2B).
Medtronic’s $2 billion in contracts represents approximately 5% of Novation’s total purchasing volume.
A weaker GPO industry could benefit wholesalers, such as Cardinal Health, by increasing their market power and allowing them to compete more effectively.
Hospital systems are consolidating, gaining leverage to negotiate directly with manufacturers, which could diminish the influence and relevance of GPOs.
With more than half of physician practices now hospital-owned, GPOs need to provide new services and contracting methods to cater to this changing landscape.
PBMs are targeting ‘buy-and-bill’ drug spending, potentially reducing the necessity for GPOs in drug pricing and contracting, which could further erode GPO influence.